9gcn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (05:34, 6 August 2025) (edit) (undo)
 
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 9gcn is ON HOLD until Paper Publication
+
==Co-crystal VHH (TPL1158_01_C09) - alpha-cobratoxin (Naja kaouthia)==
-
 
+
<StructureSection load='9gcn' size='340' side='right'caption='[[9gcn]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
-
Authors: Rivera-de-Torre, E., Burlet, N.J., Laustsen, A.H., Morth, J.P.
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[9gcn]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Naja_kaouthia Naja kaouthia] and [https://en.wikipedia.org/wiki/Vicugna_pacos Vicugna pacos]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9GCN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9GCN FirstGlance]. <br>
-
Description: Co-crystal VHH (TPL1158_01_C09) -alpha-cobratoxin (Naja kaouthia)
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9gcn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9gcn OCA], [https://pdbe.org/9gcn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9gcn RCSB], [https://www.ebi.ac.uk/pdbsum/9gcn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9gcn ProSAT]</span></td></tr>
-
[[Category: Laustsen, A.H]]
+
</table>
-
[[Category: Morth, J.P]]
+
== Function ==
-
[[Category: Burlet, N.J]]
+
[https://www.uniprot.org/uniprot/3L21_NAJKA 3L21_NAJKA] Monomer: binds with high affinity to muscular (alpha-1-beta-1-gamma-delta/CHRNA1-CHRNB1-CHRNG-CHRND) nAChR (tested on Torpedo californica, Kd=0.2-4.5 nM) and neuronal alpha-7/CHRNA7 nicotinic acetylcholine receptors (Kd=13-105 nM) (PubMed:18381281, PubMed:22223648, PubMed:9305882). Also inhibits GABA(A) channels (PubMed:26221036). Heteropentamer targets studied are composed of alpha-1-beta-3-gamma-2 (GABRA1-GABRB3-GABRG2) subunits (IC(50)=236 nM), alpha-1-beta-2-gamma-2 (GABRA1-GABRB2-GABRG2) subunits (IC(50)=469 nM), alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits (IC(50)=485 nM), alpha-5-beta-3-gamma-2 (GABRA5-GABRB3-GABRG2) subunits (IC(50)=635 nM), and alpha-2-beta-3-gamma-2 (GABRA2-GABRB3-GABRG2) subunits (IC(50)=1099 nM) (activated by 10 uM GABA) (PubMed:26221036).<ref>PMID:18381281</ref> <ref>PMID:22223648</ref> <ref>PMID:26221036</ref> <ref>PMID:30025921</ref> Homodimer: binds with high affinity (but lower than the monomeric form) to muscular (IC(50)=9.7 nM) and with low affinity to neuronal alpha-7/CHRNA7 nAChRs (IC(50)=1370 nM) (PubMed:22223648). However, it acquires (compared to the monomeric form) the capacity to block alpha-3/beta-2 (CHRNA3/CHRNB2) nAChRs (PubMed:18381281).<ref>PMID:18381281</ref> <ref>PMID:22223648</ref> Heterodimer with cytotoxin 3 (AC P01446): is slightly more active than the homodimer in inhibiting alpha-7/CHRNA7 nAChR and is considerably more active in blocking the alpha-3-beta-2/CHRNA3-CHRNB2 nAChR.<ref>PMID:22223648</ref>
-
[[Category: Rivera-De-Torre, E]]
+
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: Naja kaouthia]]
 +
[[Category: Vicugna pacos]]
 +
[[Category: Burlet NJ]]
 +
[[Category: Laustsen AH]]
 +
[[Category: Morth JP]]
 +
[[Category: Rivera-de-Torre E]]

Current revision

Co-crystal VHH (TPL1158_01_C09) - alpha-cobratoxin (Naja kaouthia)

PDB ID 9gcn

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools